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We show that the yeast, Saccharomyces cerevisiae, contains two cAMP-binding proteins in addition to the 
well-characterized regulatory (R) subunit of cytoplasmic cAMP-dependent protein kinase (PKA). We provide 
evidence that they comprise a new type of cAMP receptor, membrane-anchored by covalently attached lipid 
structures. They are genetically not related to the cytoplasmic R subunit. The respective proteins can be detected 
in sral mutants, in which the gene for the R subunit of PKA has been disrupted and a monocIonal antibody 
raised against the cytoplasmic R subunit does not cross-react with the two membrane-bound cAMP-binding 
proteins. In addition, they differ from the cytoplasmic species also with respect to their location and the peptide 
maps of the photoaffinity-labeled proteins. Although they differ from one another in molecular mass and 
subcellular location, peptide maps of the cAMP-binding domains resemble each other and both proteins are 
membrane-anchored by lipid structures, one to the outer surface of the plasma membrane, the other to the outer 
surface of the inner mitochondrial membrane. Both anchors can be metabolically labeled by Etn, myo-Ins and 
fatty acids. In addition, the anchor structure of the cAMP receptor from plasma membranes can be radiolabeled 
by GleN and Man. After cleavage of the anchor with glycosylphosphatidylinositol-specific phospholipase C from 
trypanosomes, the solubilized cAMP-binding protein from plasma membranes reacts with antibodies which 
specifically recognize the cross-reacting determinant from soluble trypanosomal coat protein, suggesting similarity 
of the anchors. Degradation studies also point to the glycosylphosphatidylinositol nature of the anchor from the 
plasma membrane, whereas the mitochondrial counterpart is less complex in that it lacks carbohydrates. The 
plasma membrane cAMP receptor is, in addition, modified by an N-glycosidically linked carbohydrate side chain, 
responsible mainly for its higher molecular mass. 
In eukaryotes, cAMP controls the activities of a number 
of key regulatory proteins by phosphorylation and 
dephosphorylation through cAMP-dependent protein kinases 
(for recent reviews see [1, 2]). The substrates of these enzymes 
are distributed all over the cell, e. g. the cytoplasm, endoplas-
mic reticulum, Golgi apparatus, secretory granules, cyto-
skeleton and nucleus [3, 4]. Accordingly, cAMP-dependent 
protein kinases (PKA) occur both in solution and associated 
with a number of cellular membranes, thus facilitating access 
to their targets. cAMP-dependent phosphorylation of these 
substrates regulates certain metabolic pathways [5] as well as 
progression through the cell cycle [6-8]. In their inactive 
state, PKA are heterotetrameric, consisting of two regulatory 
(R) and two catalytic (C) subunits. Binding of cAMP to the 
R subunits results in the dissociation of the complex, yielding 
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two active C subunits [9] (reviewed recently in [1]). In mam-
mals, at least two types of R subunits are known, Rl and R2 
[2]. Among these, a number of isoforms exist which differ with 
respect to tissue distribution, primary structure, their ability 
to be autophosphorylated and the strength of interaction with 
their C subunits. According to this, the specific pattern of 
cAMP-dependent protein phosphorylation in a particular cell 
type or tissue, depends on the subcellular distribution of the 
PKA. Little is known about the interactions that govern the 
association of the PKA holoenzyme with a number of cellular 
membranes. The derived primary sequences of both Rand C 
subunits do not contain obvious transmembrane or anchor 
sequences. Thus, PKA may be bound by high-affinity protein/ 
protein interactions to integral-membrane anchor proteins or 
by long-chain fatty acylation at the N-terminus of the C sub-
unit. Although myristoylation of some C subunits has been 
observed, the role of this co-translational modification in the 
amphitropic behaviour of some PKA is unknown [10]. In any 
case, it has been observed that cAMP causes the release of the 
soluble active C subunit [11]. 
The yeast Saccharomyces cerevisiae also contains a PKA 
of the R2C2 type, with one unique R subunit [12-14] and 
three distinct C subunit isozymes [15] which structurally and 
functionally resemble their mammalian analogues. A cyto-
plasmic location has been reported for at least the major 
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portion ofPKA in yeast [12], although a loose association of 
this enzyme with the inner face of the plasma membrane has 
also been observed [16]. Only a single structural gene for the 
R subunit (SRAl, BeYl) has been detected in this organism 
and sequenced [14, 17, 18]. 
We have been interested in whether, in yeast cells, regu-
lation of cellular functions by cAMP exists which is not me-
diated by the R subunit of cytoplasmic PKA. In fact, we 
identified membrane-associated cAMP-binding proteins in 
mitochondria [19] and in the plasma membrane (our unpub-
lished results). The vast majority of the mitochondrial protein 
was located at the outer surface of the inner mitochondrial 
membrane and constituted the R subunit of a new type of 
PKA. It failed to dissociate an active C subunit, even in the 
presence of cAMP [20]. Activation could only be achieved 
after lipolytic cleavage of the PtdIns-containing membrane 
anchor, suggesting that membrane association of this R sub-
unit provides an additional control of the kinase activity which 
is epistatic over the regulation by cAMP [21- 23]. Thus, the 
yeast mitochondrial protein kinase is amphitropic and inactive 
in its membrane-bound state. In the soluble form, the mito-
chondrial kinase phosphorylates acidic exogenous substrates 
as well as an endogenous inner membrane protein [20]. 
The recently identified third cAMP-binding protein species 
is located at the periplasmic side of the plasma membrane 
[23a]. So far no function has been attributed to this 
ectoprotein. Having established the existence of two cAMP-
binding proteins in locations and with properties which dif-
fered from those of the R subunit of the cytoplasmic PKA, 
we studied the intriguing question of their genetic relationship. 
We report here that the two new species are genetically and 
structurally unrelated to the R subunit of the known PKA. 
MATERIALS AND METHODS 
Materials 
[1-14C]Stearic acid (50-60 Ci/mol), [1-14C]myristic acid 
(50-60 Ci/mol), myo-[2-3H]inositol (15 CijmM) , D-[U-
14C]mannose (200 Ci/mol), D-[1-3H]G1cN/HCI (2-5 Cif 
mmol), [N-3H]Etn/HCl (5-30 Cijmmol) and [N-3H]acetyl-
concanavalin A (45 Ci/mmol) were from Amersham-Buchler, 
Braunschweig; 8-azidoadenosine 3',5'-( cyclic )[32P]phosphate 
(N3-[32P]cAMP, 20 Ci/mol) was purchased from ICN, Esch-
wege; N2-(2-aminoethyl)-adenosine 3',5'-( cyclic )phosphate-
Sepharose and Percoll were obtained from Pharmacia, Frei-
burg; glycosylphosphatidylinositol phospholipase C (GPI-
PLC, from T. brucel), polyclonal anti-(rabbit VSG) (VSG = 
variable surface glycoprotein) 117 and 221, anti-CRD serum 
(CRD = cross-reacting determinant) and the soluble antigens 
117 and 221, were gifts from P. Overath, Tubingen; a polyclo-
nal anti-(VSG-CRD) serum was also kindly donated by A. 
Mehlert and M. Ferguson, Dundee; GPI-PLD from rabbit 
serum was a gift from W. Gutensohn, Munchen; 12-myristoyl-
phorbol 13-acetate (TPA) was bought from Serva, Heide1-
berg; silica gel G and soft plus Si-60 thin-layer plates were 
from Merck, Darmstadt; all other chemicals were obtained as 
described [21]. 
Yeast strains, growth conditions and preparation 
of mitochondria and plasma membranes 
Cells of the haploid protease-deficient strain ABYS1 
MATrx pral-l prbl-l prc1-l cpsl-3 ade, lacking the vacuolar 
proteinases A and B, carboxypeptidases Y and S [24] and of 
the SRAl-disruption mutant EG273-5A MATrx leu2 ura3 his4 
ade2-l bcyl :: HIS3 [17] were grown at 30°C to log phase 
in lactate medium and harvested at a titer of 107 cells/ml. 
Mitochondria were prepared from spheroplasts by osmotic 
lysis and differential centrifugation and purified by Percoll-
density-gradient centrifugation [21]. Plasma membranes· were 
isolated from whole-cell homogenates by two successive den-
sity-gradient centrifugations on Percoll (28%) and sucrose 
(15-28%), taking the binding of radiolabeled concanavalin 
A as a criterion for recovery. Finally, the crude plasma mem-
branes were spun through a cushion of 0.5 M sucrose. The 
pellet was resuspended in 0.25 M sucrose, 1 mM EDTA and 
20 mM Mops/KOH, pH 7.4, at 2.5 mg/ml. Mitochondrial in-
ner membranes were prepared according to [19]. 
Metabolic labeling and TLC-analysis 
ABYSl cells were grown overnight in semisynthetic me-
dium containing 1.8 g/l yeast nitrogen base (Difco), 5.2 g/l 
(NH4hS04, 2% lactate and 0.1 % glucose. Mter growth of 
the cells to an absorbance at 600 nm of 1 0 -15, in the presence 
of one of either 1.0 mCi [14C]stearic acid and 0.2 mCi [3H]_ 
stearic acid, 0.5 mCi p4C]myo-Ins and 0.25 mCi [3H]myo-Ins, 
200 JlCi p4C]G1cN and 25 JlCi [3H]G1cN, 275 JlCi 
[14C]mannose and 125 JlCi [3H]mannose or 350 JlCi [14C]Etn 
and [3H]Etn for 2 h at 30°C, a WOO-fold excess of the respec-
tive unlabe1ed compound was added as described previously 
[22] and mitochondria and plasma membranes were prepared. 
The cAMP-binding proteins were partially purified by affinity 
chromatography on cAMP-Sepharose, subjected to chemical 
and enzymic degradations and the cleavage products analysed 
by TLC (after extraction oflipids). 
Partial proteolysis 
Photoaffinity-Iabeled membranes or partially purified pro-
teins were precipitated with 13% poly(ethylene glycol) 6000, 
washed with 0.5 mg/ml8% poly(ethylene glycol), dissolved in 
either 20 mM (NH4hC03, pH 7.8, containing 0.5% Mega 10 
(for V8 protease) or 50 mM (NH4hC03 , pH 8.2, plus 0.2% 
Chaps (for trypsin) and incubated with either 15 Jlg/ml V8 
protease from Staphylococcus aureus (25°C, 60 min) or 30 Jlgj 
m1 trypsin (treated with N-tosyl-L-phenylalanine chloro-
methane O°C, 90 min), in a total volume of 250 Jll. Mter the 
addition of a twofold molar excess of rx2-macroglobulin, a 
fourfold molar excess of soya-bean trypsin inhibitor and 
200 JlM phenylmethylsulfonyl fluoride (0° C, 5 min), the 
samples were precipitated with 5% trichloroacetic acid, 
washed twice with acetone and resuspended in sample buffer 
for SDSjP AGE. i 
Western-blot analysis it 
The unstained gel was soaked in 100 ml25 mM Tris/HCl, 
pH 8.3, 200 mM glycine, 20% methanol plus 0.02% (mass/ 
vol.) SDS, for 15 min at 4°C, placed into a vertical electroblot 
apparatus and the proteins transferred to nitrocellulose. Mter 
electrophoresis (40 V, 14 h, 4°C) the nitrocellulose sheet was -
incubated in 100 ml 20 mM Tris/HCl pH 7.4 and 150 mM 
NaCI (buffer A) plus 5% (mass/vo!.) fat-free milk powder for 
1 h at 22°C. The sheet was then incubated with the antibody 
(WOO-fold dilution in the above buffer) overnight at room 
temperature. Unbound antibody was removed by washing 
three times with 100 ml buffer A for 30 min. 12sI_labeled 
rabbit anti-(mouse Fab) serum [0.75 JlCifor anti-(R/C) serum] 
or mouse anti-(rabbit IgG) serum [0.15 ~Ci for anti-(CRD) 
serum] was added to 15 ml 5% milk powder in buffer A and 
incubated with the fIlter for 1 h at 22°C. Excess reagent was 
washed away with buffer A. The fIlter was exposed to Kodak 
X-Omat AR-5 fIlm at -80°C for 7 d using eight-times in-
tensifier screen. 
Immunoprecipitation 
0.25 mg photoaffinity-labeled membrane protein 
(7500 dpm) from plasma membranes or mitochondria was 
solubilised in 0.5% Mega 10 and centrifuged at 150000 g for 
1 h. Subsequent precipitation of the supernatant was with 
13 % poly( ethylene glycol) 6000 and, after dissolving in 10 mM 
Tris/HCI, pH 8.0, 150 mM NaCI and 0.05% Triton X-lOO, 
the solubilised material was dissolved in 1 : lOO-diluted rabbit 
anti-(VSG-CRD) serum, directed against VSG-117 of try-
panosomes. Purification was by affinity chromatography on 
VSG-121 (anti-CRD serum). Incubations were performed in 
the presence or absence of purified soluble VSG for 2 h at 
4°C. After the reaction with 50 ~ mouse anti-(rabbit IgG)-
agarose for 30 min at 4°C, the agarose beads were washed 
three times with immunoprecipitation buffer, twice with buffer 
lacking Triton X -100, dissociated in 60 mM Tris/HCI, pH 6.8, 
2% SDS, 5% mercaptoethanol, 10% glycine and analysed by 
SDS/PAGE and autoradiography. 
Miscellaneous procedures 
Preparation of shocked mitochondria [21], photoaffinity 
labeling with N3-e2p]cAMP [25], affinity purification on 
cAMP-Sepharose [26], hydrophilic/hydrophobic partitioning 
using Triton X-114 [22], protein determination [27], SDS/ 
PAGE [28], native gel electrophoresis [29] and fluorography 
using ENHANCE [30] were performed according to published 
procedures. 
RESULTS 
Physical analysis of two membrane-bound cAMP-binding 
proteins 
Yeast is generally agreed to have a single cAMP-binding 
protein {12, 14], which is the R subunit of the cytoplasmic 
type-II protein kinase and regulates three different C subunits 
[15]. cAMP has been observed to bind to receptor proteins 
occurring in three different compartments of the yeast cell: 
the cytoplasm (12], mitochondria [19] and plasma membranes 
[23a, 31]. Their structural and functional relationships are 
unknown. Previous [21-23] and the present studies (Fig. 1) 
show that, in contrast to the cytoplasmic R subunit of PKA, 
the latter two cAMP-receptor proteins are membrane-bound 
and exhibit properties which point to the nonidentity of the 
three. Therefore, we undertook a comparative study to eluci-
date whether they are derived from a single gene or constitute 
separate, structurally and genetically unrelated cAMP-bind-
ing proteins. For the cytoplasmic R subunit, a molecular mass 
of 52 kDa was reported [12]. Unfortunately, no such protein 
can be labeled with N3-[32p]cAMP to a significant extent in 
dialysed cytoplasmic fractions. (However, the presence of this 
species can be proven immunologically as shown in Fig. 3, or 
after affinity purification as shown in Fig. 4.) Purified plasma 
membranes, photoaffinity-labeled with N3-e2p]cAMP, dis-
play one major 32P-Iabeled protein species which has an 
dectrophoretic mobility corresponding to a species of 54 kDa 
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Fig. 1. Photoaffinity iabeling of cAMP-binding proteinsfrom mitochon-
dria and plasma membranes. 100)lg intact or detergent-solubilized 
(0.5% Mega 10; Det) spheroplasts (SP), 100)lg osmotically lysed 
spheroplasts (HO), 25 )lg plasma-membrane vesicles (PM) and 25 )lg 
mitochondria (MT) were photoaffinity labeled with N r [32p]cAMP 
in the presence or absence ofunlabeled cAMP and N-glycanase (Gly). 
After adjusting to 0.5% Mega 10. the supernatant of a centrifugation 
150000 xg, 30 min) was chromatographed on cAMP-Sepharose, the 
high-salt eluate precipitated with 8% poly(ethylene glycol) 6000 and 
the pellet analysed by SDS(PAGE. Molecular mass markers were run 
in parallel on the same gel 
(Fig. 1, lane 5). Treatment with N-glycanase reduces the ap-
parent molecular mass to about 42-44 kDa, indicative of 
the removal of (an) N-glycosidicaIly linked carbohydrate side 
chain(s) (Fig. 1, lane 6). The molecular mass of the mitochon-
drial version was found to be 46 kDa [19]. SDS/PAGE of 
photoaffinity-Iabeled proteins from purified mitochondria is 
consistent with the published data (Fig. 1, lane 7). N-glycanase 
has no effect on the electrophoretic mobility of the mitochon-
drial species (Fig. 1, lane 9) in agreement with the presumed 
import pathway of this protein. The minor band seen in Fig. 1, 
lanes 7 - 9, is unlikely to represent a specific cAMP-binding 
species, because excess unlabeled cAMP does not compete 
(Fig. 1, lane 8). Fig. 1 also shows that mutual contamination of 
plasma membranes and mitochondria is low (compare Fig. 1, 
lanes 5 and 7). In cell homogenates, however, both species can 
be affinity-Iabeled simultaneously (Fig. 1, lane 3) whereas in 
spheroplasts only the cAMP receptor from plasma membranes 
can be labeled (lane 1). Since the mitochondrial 46-kDa species 
is readily affinity labeled in detergent-treated (Fig. 1, lane 2) 
or osmotically lysed spherosplasts (lane 3 and 4), this failure 
is likely to be due to an accessibility barrier for N3-cAMP 
provided by the plasma membrane and suggests an outward 
orientation of the plasma-membrane protein. Thus, the data 
compiled in Fig. 1 demonstrates that the two membrane-
bound proteins, which can be affinity-labeled with N3-
[32p]cAMP are separate entities having different molecular 
masses and, residing in two different cellular compartments. 
Immunological analysis of the cAMP-binding proteins 
As the next step, we assayed the immunological relation-
ship of the soluble R subunit of PKA to the two-membrane-
bound cAMP receptor proteins. A monoc1onal antibody 
against the cytoplasmic R subunit was used in order to test 
the possibility that yeast PKA is amphipathic and that the 
two membrane-embedded forms constitute structural and 
topological variants of the latter. In addition, an antibody 
against the cytoplasmic Cl subunit was used to test the pos-
sible identity with this protein of the putative C subunits 
associated with the two membrane-bound receptors. Fig. 2 
shows that both antibodies recognize only the authentic cyto-
plasmic proteins against which they had been raised (lanes 
9, 11 and 12). The reported molecular masses of both the 
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Fig. 2. Immunological relationship between three cAMP-binding proteins from yeast. 80 Ilg membranes from mitochondria (MT) or plasma 
membranes (PM), in 0.5% Mega 10 or 0.75% octyl glucoside, respectively, 251lg affinity-purified cAMP-binding protein (Receptor) from 
mitochondria and plasma membranes and 150 Ilg cytoplasmic proteins (Cytoplasm) were separated by SOS/PAGE (14.5% gel), the proteins 
transferred to nitrocellulose and reacted with mouse antibodies directed against either the cytoplasmic isozyme Cl> anti-C mAbZ48, (C), or 
the R subunit of the cytoplasmic PKA, anti-R mAb427 (R). The blot was incubated in 125I-Iabeled rabbit anti-(mouse Fab fragment) serum. 
In control incubations, 5 Ilg affinity-purified C or R subunits of PKA were present as competitors (Con). Another control was carried out 
using preimmune serum (IgO), photoaffmity-Iabeled mitochondrial (46 kOa; MT) and plasma membrane (54 kOa; PM). cAMP-binding 
proteins served as markers (Ma). Molecular masses of cytoplasmic Rand C subunits were 52 kOa 
cytoplasmic R and Cl subunits are 52 kDa [12, 15, 32]. No 
cross-reactivity was observed with the mitochondrial 46-kDa 
protein (Fig. 2, lanes 3 and 4) and the plasma membrane 54-
kDa cAMP receptor proteins (lanes 1 and 2). Also, cellular 
subfractionation and purification by affinity chromatography 
(Fig. 2, lanes 5 - 8) did not change this results. This finding 
indicates that the known cytoplasmic R subunit is 
immunologically not related to either of the two membrane-
bound cAMP-binding proteins and, in particular, makes it 
rather unlikely that the cytoplasmic R subunit is simulta-
neously the precursor of the other two. In addition, it is evident 
from these results that the C subunit, usually found tightly 
associated with the non-activated mitochondrial-membrane-
embedded cAMP receptor [33], is not Cl. 
Genetic approach 
To support this important finding, we also took a genetic 
approach. We used a strain in which the structural gene for 
the cytoplasmic R subunit of PKA, SRA1, had been partly 
deleted and replaced by the HIS3 selective marker gene [17]. 
We prepared and labeled spheroplasts, plasma membranes 
and mitochondria with N3-[32p]eAMP and, by SDSjPAGE, 
analysed the fractions for the presence of the membrane-
bound cAMP-binding proteins (Fig. 3). We made three obser-
vations. (a) Specific signals were found in all three fractions 
obtained from the mutant (Fig. 3, lanes 3, 5 and 10). The 32p 
was competed for by excess unlabeled cAMP (Fig. 3, lanes 4, 
6 and 11). The electrophoretic mobility of the protein from 
plasma membranes could be decreased by N-glycanase treat-
ment as for the wild-type protein. These properties suggest 
that the affmity-Iabeled membrane proteins are related to 
those labeled by 32p in the wild type (Fig. 3, lanes 1 and 8) 
and indicate that the R subunit of PKA from plasma mem-
branes and the cAMP-binding proteins from mitochondria 
are encoded by different genes. (b) It is evident from Fig. 3 that 
the apparent molecular mass of the deglycosylated cAMP-
binding protein, which can still be 32p labeled in plasma mem-
branes from sral mutant cells (Fig. 3, lanes 3 and 5), is higher 
(50 kDa) than in the wild-type (47 kDa)(Fig. 3,lane 1, see also 
lane 7). Since this difference is maintained after the removal 
of N-glycosidic carbohydrate chains, this observation could 
mean that, in the sral mutant, a (presumably C-terminal) 
processing event did not occur. A more trivial explanation 
that the different electrophoretic mobiIities ofthe 32P-labeled 
plasma-membrane proteins from the two stains reflects strain-
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Fig. 3. cAMP-binding proteins in plasma membranes and mitochondria 
of a yeast strain deficient in the R subunit of P KA. Plasma membranes i. 
(PM), spheroplasts (SPH) and mitochondria (M) from the wild-type i 
strain, ABYS 1 (STRAIN W) and.the SRAl /BCY 1 disruption mutant, ~ 
EG273-5A (STRAIN M), were photoaffmity-Iabeled with N3- ~ 
[32p]cAMP (LABELING) in the presence or absence of an excess ~ 
of unlabeled cAMP and digested with N-glycanase. Subsequently, f 
plasma membranes (lanes 5 and 6) or mitochondria (lanes 12 and 13) r 
were prepared from the spheroplasts. The plasma membrane and • 
mitochondrial fractions were analysed by SOS/PAGE and auto- a 
radiography. For comparison of molecular masses, aliquots of plasma ~ 
membranes from wild-type and mutant cells (W + M, lane 7), contain- ~ 
ing equal amounts of radioactive material, were mixed together and I' 
analysed simultaneously. Molecular masses were derived from marker 
proteins run in parallel on the same gel. Identical amounts of plasma 
membranes (75 Ilg), mitochondria (125 Ilg) and spheroplasts (675 Ilg) 
from wild-type and mutant cells were used for the photoaffinity 
labeling 
specific peculiarities in O-glycosylation.cannot, however, be 
ruled out. (c) In comparison to the wild-type strain, little , 
photoaffinity-Iabeled material is found in the plasma-mem- K 
brane fraction and in spheroplast membranes from the mutant 
strain (Fig. 3, lanes 3 and 5). Moreover, this portion is signifi-
cantly lower than that observed after photoaffinity-Iabeling 
of cell homogenates (data not shown). This finding argues P 
that the receptor, or a precursor form thereof, is retained in 
an intracellular compartment, most likely the endoplasmic 
reticulum or the Golgi, due to the unregulated activity of the 
protein kinase in this mutant. 
In contrast, the molecular mass of the mitochondrial 
cAMP-receptor protein is unchanged in the mutant compared 
to the wild type (Fig. 3, lane 8 versus lane 10), suggesting "-
different regulation of the biosynthetic processing pathway; ~ 
for the mitochondrial and the plasma-membrane protein. 
However, in contrast to the plasma-membrane isoprotein, th·: 
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Fig. 4. Comparative peptide mapping of three cAMP-binding proteins 
from yeast. Solubilized photoaffinity-Iabeled cAMP-binding protein 
from cytoplasm (200 J.lgjlane; C), plasma membrane (125 J.lgflane; P) 
and mitochondria (75 J.lg/lane; M), were digested with V8 protease 
(V) or trypsin (T) in the presence or absence of SDS and 6 M urea 
(SDS). Subsequently, aliquots were digested with N-glycanase (Gly) 
and all samples analysed by SDSjPAGE [58] (gel system ofSchiigger 
and von Jagow) and fluorography. The molecular masses indicated 
at the left margin were derived from marker proteins run in parallel 
on the same gel 
total concentration of the mitochondrial cAMP receptor is 
diminished in a sral mutant simultaneously in mitochondria 
and in cell homogenates (data not shown). Taken together, the 
results prove that the two membrane-bound cAMP-receptor 
proteins are encoded by gene(s) different from these coding 
for SRAl. 
Peptide mapping 
To prove the difference between the cytosolic R subunit 
and the two membrane-bound cAMP-binding proteins at the 
level of the protein structure, and to examine a possible struc-
tural relationship between these two proteins, a peptide-map-
ping study of all three photoaffrnity-labeled proteins was 
undertaken (Fig. 4). 
The native and the denatured forms were digested with 
two different pro teases, either V8 protease or trypsin, respec-
tively. All three species were partly purified by cAMP affinity 
chromatography. The peptide maps of the native (Fig. 4, lane 
10) and denatured cytoplasmic species Oanes 11 and 12), can 
clearly be discriminated from the respective patterns of the 
isoproteins from mitochondrial membranes and plasma mem-
branes. This result confirms that the cytoplasmic isoproteins 
and the two membrane-boundisoproteins differ. 
However, the V8 digests of the native, affinity-purified 
and subsequently photoaffrnity-Iabeled cAMP receptors from 
mitochondria and plasma membranes differ from one another 
(Fig. 4, lanes 2 and 7). This difference is not exclusively due to 
the fact that the plasma-membrane protein is N-glycosylated, 
whereas the mitochondrial species is not (evident from a com-
parison of Fig. 4, lanes 8 and 9 with lanes 5 and 6, respective-
ly). The V8 peptide maps of the native cAMP-receptor pro-
teins, affinity-purified from the two membrane fractions, also 
differed when plasma membranes were previously treated with 
"1-glycanase (compare Fig. 4, lane 1 with lane.2). But, as soon 
~tS the N-glycanase-treated protein from plasma membranes 
·md the mitochondrial species are compared unfolded; in the 
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presence of SDS, they yield degradation patterns with two 
different proteases which are indistinguishable by SDS/PAGE 
(compare Fig. 4, lanes 3 and 5 with lanes 4 and 6, respectively). 
This finding argues that the two membrane-bound isoproteins 
have identical or very closely related primary structures and 
that the differences observed between the native confor-
mations of the two must be due to different folding structures. 
It has been observed previously that the presence or absence 
of a Ptd!ns-anchor significantly influences the tertiary struc-
ture of a cAMP-receptor protein [22]. Although the 32p may 
be on only one cAMP-binding site of the receptor, [34] and 
thus the present results do not provide direct proof, the simi-
larities in electrophoretic mobilities and in the peptide-degra-
dation patterns of the deglycosylated, denatured proteins may 
be interpreted as a first indication of a close structural relation-
ship between the two topologically different, membrane-
bound isoproteins. Their genetic relationship, however, still 
has to be elucidated. 
Characterization of the lipid membrane anchors 
by phospholipases 
Previous work on the mitochondrial cAMP-receptor pro-
tein [20, 22] has demonstrated that it is anchored to the outer 
surface of the inner membrane by a Ptdlns-containing lipid 
moiety. Similar lipid structures, i.e. GP! anchors, have so 
far only been observed with ectoproteins from a variety of 
organisms, including yeast [35 -40]. We compared the 
susceptibilities of the two anchors to GPI·specific 
phospholipases in vitro, tested the metabolic labeling, ident-
ified the anchor constituents by TLC and analysed the 
immunological properties of the two structures. 
An increasing number of GPI-anchored ectoproteins have 
been found at the extracellular face of a variety of cell types 
from many different organisms. They can be released from 
their resident cells by GPI -specific phospholipases and thereby 
rendered hydrophilic. This release by PtdIns or GPI-specific 
phospholipases serves as a diagnostic tool in proving anchor-
age by a GPI structure [35, 41, 42]. To analyse the nature of 
the anchoring structures of the two membrane-bound cAMP 
receptor proteins, we treated them with GP!-PLC from 
trypanosomes and phospholipase D from rabbit serum 
(Fig. 5). Both the release from the membrane fraction into the 
soluble supernatant after centrifugation (Fig.5A) and the 
concomitant increase in hydrophilicity upon removal of the 
lipid part of the anchor (Fig. 5B), were measured. In addition, 
it was observed previously [23] that, with the mitochondrial 
cAMP-binding protein, a natural lipolytic liberation mecha-
nism could be activated by lipids (particularly efficiently by 
TPA) , in the presence of Ca2+ and ATP. Therefore, it was 
determined whether such a mode of release from the mem-
brane also existed for the counterpart from plasma mem-
branes. Hydrophilicity was assayed by Triton X -114/aqueous-
phase partitioning. Salt (or MeMan, not shown) was used to 
assist membrane release of the plasma membrane protein. 
Fig. 5 shows that, in contrast to the mitochondrial cAMP 
receptor [23], the isoprotein from plasma membranes fails to 
be liberated by a TPA-activated endogenous phospholipase. 
This observation reveals an additional difference between the 
two membrane-bound cAMP receptor proteins. Both anchors 
can be cleaved by GPI-PLD from rabbit serum, proving their 
phospholipid nature. Surprisingly, the releasing efficiency is 
poor with phospholipase A2 and hydroxylamine which both 
cleave oxy esters. It is also unexpected that Ptdlns-PLC from 
B. cereus and Bacillus thuringiensis fail completely to cleave 
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Fig. S. Membrane release of cAMP-binding proteins. Photoaffmity-
labeled shocked mitochondria (MT) were prepared by sixfold dilution 
of the 32P-labeled mitochondria with 10 mM Hepes/KOH, pH 7.2, 
0.5 mM EDTA, 2S mM KCl and gentle stirring on ice for 30 min, and 
plasma membranes (PM, 2S0 IJ.g protein) were incubated with buffer 
(Control), SO IJ.M Ca2+ plus O.S IJ.g/ml TPA (Ca2+ /TPA), phospho-
lipase C from T. brucei (PLC) or phospholipase D from human serum 
(PLD) as described previously [23, 23a]. Half of the incubation mix-
ture then received 1 M NaCI (filled bars) whereas to the other aliquot 
the same volume of water was added (open bars). Subsequently, the 
membranes were either centrifuged through 0.5 ml cushions ofO.S M 
sucrose (1 SO 000 x g, 30 min) or subjected to Triton X-114 partition-
ing. The radioactivity of the supernatant and pellet fractions of the 
centrifugation and the aqueous and detergent phases of the partition-
ing was determined. The sum of both supernatant and pellet fractions, 
or of aqueous and detergent phases, were set at 100% of total radioac-
tivity 
the mitochondrial anchor and leave a significant portion of 
the anchor of the plasma-membrane cAMP receptor un-
digested (not shown). Nevertheless, the anchor from both the 
mitochondrial and plasma-membrane cAMP-binding protein 
can be cleaved by GPI-PLC from T. brucei, albeit with modest 
efficiency. Although it has been observed [43, 44] that in some 
instances GIP-anchored VSG are not efficiently cleaved by 
trypanosomal phospholipase C, the exact reason for this be-
haviour in the case of the yeast protein is not yet known. 
Taken together, cleavability of the two membrane anchors by 
GPI-PLC and GPI-PLD provide strong evidence for their 
anchorage by a lipid structure. 
Fig. 5 also reveals differences between the two cAMP re-
ceptors with respect to interaction with the membrane (or 
an integral-membrane anchor protein) of the (glyco )protein 
moieties. After lipolytic cleavage of the membrane anchors 
by either phospholipase C or D, efficient release from the 
membranes of the plasma-membrane protein requires the 
presence of either high salt (Fig. 5) or MeMan or deglycosyla-
tion (not shown), whereas solubilization of the mitochondrial 
counterpart does not require further treatment. This indicates 
that the cAMP receptor from the plasma membrane interacts 
with the membrane additionally through the carbohydrate 
side chain. 
Immunological study of anchor epitopes 
The GPI anchor of the VSG from trypanosomes was ob-
served to harbour a number of immunogenic determinants 
which were primarily responsible for the cross-reactivity be-
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Fig. 6. Western-blot analysis of the cAMP-binding proteins with anti-
VSG serum. Plasma membranes (PM; 20 or SO IJ.g), intact or detergent-
solubilized (Det) mitochondria (MT; 90 IJ.g) and inner mitochondrial 
membranes (IM; 70 J!g) were incubated with 10 U GPI-PLC from T. 
brucei (PLC). Where indicated, mitochondria were treated with SO IJ.M 
Ca2+ and 10 J!g/ml TPA (Ca2+ /TPA) as described, then adjusted to 
O.S% Mega 10. Samples were partially purified by cAMP-Sepharose 
affinity chromatography, precipitated with poly(ethylene glycol) 6000 
(8%) and analysed by SDS/PAGE (14.S% gel). In parallel, on the 
same gel, purified soluble VSG-117 protein (VSG) was electro-
phoresed (lanes 13 and 14). After transfer to nitrocellulose and satu-
ration of free binding sites with SO mg/ml bovine serum albumin, the 
lanes were incubated separately with two different polyclonal rabbit 
anti-VSG sera (serum A, anti-VSG-117 serum; serum B, anti-VSG-
221 serum; both from Overath, each diluted 1 : 1000). Molecular-mass 
standards were run in parallel on the same gel 
tween different VSG [42, 45, 46]. One epitope is constituted 
by unmodified GleN, another one by the Ins-1,2-(cyclic)-
phosphoester generated upon cleavage by GPI-PLC [46]. In 
order to verify the (glyco )lipid nature of the two yeast mem-
brane anchors, we used polyclonal antibodies raised against 
two different soluble VSG and assayed for cross-reactivity 
with the yeast membrane anchor structures. 
Fig. 6 shows a Western-blot experiment where the yeast 
proteins have been reacted with two polyclonal anti-CRD sera 
(A and B) raised against a GPI-PLC-treated soluble VSG 
and affInity-purified by using a different VSG. The affinity-
purified cAMP-binding proteins from yeast were treated with 
GPI-PLC or, in the case of the mitochondrial PtdIns lipid-
anchored protein, with TPA in the presence of Ca2 + and ATP, 
then electrophoresed and blotted. The plasma-membrane pro- f. 
tein yields a single although weak signal after immuno-
precipitation at a position which agrees with its apparent 
molecular mass of 54 kDa (Fig. 6, lanes 1, 2, 7 and 8). An ;~ 
immunoprecipitation signal is lacking where the treatment 
with PLC has been omitted (compare, e.g. lanes 1 and 3 in , 
Fig. 6). This indicates that cleavage by GPI-PLC is required 
to generate at least one of the epitopes. The membrane anchor 
from the mitochondrial isoprotein does not immunoprecipi- . 
tate (Fig. 6, lanes 4 - 6 and 10 -12) indicative of the absence r 
of at least one of the epitopes, most likely the non-acetylated 
GleN [21] generally found in GPI (see also Figs 8 and 9 B). In 
the control, authentic soluble (i.e. PLC-cleaved) VSG yields 
a strong immunoprecipitation signal at the expected position 
in the blot with the respective homologous antiserum (Fig. 6, 
lane 13) but a weak cross-reaction with the heterologous serum 
(lane 14). This reflects the fact that the sera recognize both 
protein and glycolipid determinants [4S} and proves that the 
intensity with soluble heterologous VSG and with the affInity-
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Fig. 7. lmmunoprecipitation of the cAMP-binding proteins with anti-
VSG serum. 500 Jig plasma membranes (PM), mitochondria (MT) 
and inner ?Iitochondrial membranes (IM) were photoaffinity-Iabeled, 
treated with PLC from T. brucei (PLC) or Ca2+ /TPA as above, 
solubilized by detergent, precipitated with poly(ethylene glycol) 6000, 
dissolved in 10 mM Tris/HCI, pH 8.0, 150 mM NaCl and 0.5% Triton 
X-lOO and incubated with a 1: 100 dilution of either the polyclonal 
rabbit anti-VSG-117 serum (serum A) or anti-VSG-221 serum (serum 
B) in the presence (1 or 10 Jll) or absence of the homologous purified 
soluble VSG 117 antigen (in the case of serum A) or VSG-221 antigen 
(in the case of serum B) for 2 h at 4 QC. After the reaction with 50 J.1l 
anti-(rabbit IgG) - agarose from mouse for 30 min at 4 QC, the agarose 
beads were washe4 .three times with buffer (as above), twice with 
buffer lacking Triton X -100, dissociated in sample buffer and analysed 
by SDS/PAGE and autoradiography. Authentic photoaffinity-labeled 
cAMP-binding protein from plasma membranes was run as a marker 
(M) on the same gel 
purified yeast protein is due to the cross-reactivity with the 
anchor structure. 
Fig. 7 confirms these results. It shows an autoradiogram 
of material from yeast, immunoprecipitated by polyclonal 
anti-VSG and anti-CRD sera (A and B). The signal is weak 
although significant in those cases where treatment with GPI-
PLC has been omitted (Fig. 7, lanes 7 - 9). This faint signal 
may be ascribed to the reaction with the epitope constituted 
by non-acetylated GleN (see below). Treatment of plasma 
membranes with trypanosomal PLC greatly enhances the 
immunoreactivity of the 54-kDa cAMP-binding protein, 
probably due to the generation of an additional cross-reacting 
determinant in the form of the myo-inositol-1,2-cyclic 
phosphoester (lanes 1 - 3 and 4 - 6 in Fig. 7). Since homolo-
gous soluble VSG competes (lanes 1,2,4 and 5 in Fig. 7), the 
immune reaction is considered specific. Again, no precipitate 
is formed with the protein from mitochondria (Fig. 7, lanes 
12, 13) and mitochondrial inner-membrane vesicles (lanes 
10,11). 
Comparative analysis oJ anchor constituents 
The data shown in Figs 6 and 7 suggest a close structural 
similarity between the GPI anchor of VSG (the classical ex-
ample of a GPI) and the structure linking the cAMP-binding 
protein to the plasma membrane of yeast. The anchor struc-
ture of the mitochondrial isoprotein is not recognized by these 
antibodies. To elucidate the structural basis for the different 
immune reactivity of the two anchors from yeast, we studied 
the constituent building bricks. We metabolically labeled yeast 
cells with compounds found in protozoan and vertebrate GPI 
and observed (Fig. 8) that [14C]myristate pulse-labels the 
cAMP-receptor protein from plasma membranes (Fig. 8, lanes 
4 and 5), whereas, in confirmation of previous observations 
[22], the mitochondrial isoprotein is preferentially labeled by 
[14CJstearate (lane 1). Both 14C atoms can be removed from 
305 
the core proteins by treatment with either GPI-PLD and, less 
efficiently, with trypanosomal PLC (not shown), indicating 
that the 14C label resides in the lipid anchor and not in amino 
acids of the protein moiety. Results (G. Miiller, unpUblished 
results) show that after complete hydrolysis of the meta-
bolically labeled anchor structure and subsequent TLC, most 
of the 14C can be reisolated with the respective component 
used for labeling. Both anchor structures contain myo-Ins 
and Etn (Fig. 8, lanes 6, 7 and 8-10, respectively). Only the 
cAMP-binding protein from plasma membranes is labeled by 
[3H]GlcN and p4C]Man (Fig. 8, lanes 12 and 16, respectively). 
These labels are not removed by treatment with N-glycanase 
(Fig. 8, lanes 14 and 17), indicating that they are not exclus-
ively contained in N-glycosidic side chains. Recent obser-
vations (our unpublished results) show that the residual carbo-
hydrate label, in fact, is associated with the anchor and not 
with O-glycosidic side chains. Thus, the anchor structure of 
the cAMP receptor from plasma membranes can be labeled 
by components which are typical of GPI anchors, whereas the 
lipid anchor of the mitochondrial cAMP-binding protein lacks 
carbohydrates (Fig. 8, lanes 11 and 15). Since, during translo-
cation through the secretory pathway, GPI are transferred to 
the protein (in a pseudo-transpeptidation reaction by means 
of the amino group of Etn) on the endoplasmic reticulum [37, 
47, 48], the results from the metabolic-Iabeling experiments 
are in agreement with the presumed biosynthetic and transport 
pathways of the two proteins. 
In order to identify the constituents of the two anchors 
directly and to study their order of linkage, we degraded 
metabolically labeled and partially affinity-purified cAMP-
binding proteins by a number of anchor-specific enzymic and 
chemical-cleavage reactions and analysed the products by 
TLC. Cells were labeled with [3HJEtn, the purified cAMP 
receptors digested to completion with pronase, then chroma-
tographed by TLC in two adjacent lanes (Fig. 9 A). The two 
lipid structures retain the 3H and chromatograph to non-
identical positions on the plate. This reflects the fact that 
they differ structurally from one another. None of the spots 
migrates as far as any of the marker substances used, 
suggesting that they are more complex and less hydrophobic 
than the marker substances. Particularly the anchor fragment 
from the plasma-membrane protein appears to be more 
hydrophilic than that from mitochondria, probably due to a 
higher carbohydrate content which is not altered by treatment 
with N-glycanase. This behaviour proves that the large carbo-
hydrate side chain does not branch from the lipid anchor but 
is likely to be attached N-glycosidically to internal sequences 
of the protein moiety. 
Nitrous acid cleaves nonacetylated GleN residues [46]. 
Fig. 9B shows that, after in vivo labeling with [3H]myo-Ins, 
only the anchor from the plasma-membrane protein is affected 
by nitrous acid, in agreement with the finding (Fig. 8, lanes 
11-14) that only the anchor of this protein contains GleN. 
Cleavage by nitrous acid simultaneously increases the hydro-
phobic character of the 3H-Iabeled residual anchor fragment, 
consistent with the assumption that (some) carbohydrate resi-
dues have been removed by this treatment. The 3H-Iabeled 
cleavage product co-migrates with PtdIns, in agreement with 
results obtained with GPI anchors from T. brucei and some 
vertebrate ectoproteins [37, 38,46]. This also argues that the 
inositol ring is not substituted by an additional fatty acid. The 
anchor of the mitochondrial isoprotein is not visibly affected 
by this treatment and most likely remains attached to the core 
protein, since it does not migrate from the origin of the TLC 
plate (in contrast to the pronase-treated protein in Fig. 9 A). 
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Fig. 8. Metabolic labeling of the mitochondrial and plasma membrane cAMP-binding proteins. Yeast cells were metabolically labeled with 
p4C]stearic acid (ST), [14C]myristic acid (MY), [14C]myo-inositol (IN), [14C]ethanolamine (EA), [14C]glucosamine (GLA) or [14C]mannose 
(MAN) and subsequently fractionated into mitochondria (M) and plasma membranes (P). The cAMP-binding proteins were enriched from 
detergent extracts of the mitochondria (0.5% Mega 10) and plasma membranes (0.75% octyl glucoside) by affinity purification using cAMP-
Sepharose. Where indicated, half of the plasma membrane or mitochondrial fractions, eluted from the affinity column by 0.1 M cAMP. was 
digested with N-glycanase (Gly). All samples were subsequently dissolved in sample buffer, boiled for 5 min at 95°C and centrifuged. The 
supernatants were analysed by SDS/PAGE and fluorography 
Degradation by GPI-PLD removes the inositol ring, 
releasing the fatty acid associated with the respective phos-
phatidic acids (Fig. 9C). (For these and the following exper-
iments, Fig. 9 D and E, cells have been labeled separately with 
either of the two 3H-Iabeled fatty acids.) The identification of 
phosphatidic acids as the residual fragments in both instances 
leads to the conclusion that, in the case of the mitochondrial 
protein, GPI-PLD must have removed a large constituent, 
most likely the core protein. 
Acetolysis exchanges the phosphoric acid of the lipid for 
an acetyl residue, yielding 1,2-dimyristoyl-3-acetylglycerol 
and 1,2-distearyl-3-acetylglycerol (Fig. 9 D), in agreement 
with the metabolic-labeling data (Fig. 8, lanes 1 and 4) and as 
a confirmation of the presumed structure. 
Base hydrolysis cleaves fatty-ester bonds. The 3H left over 
from the mitochondrial protein anchor structure co-migrates 
with stearic acid and that from plasma membranes co-mi-
grates with myristic acid, again in agreement with the in vivo 
3H-Iabeling data (Fig. 8, lanes 1 and 4). This demonstrates 
the ester nature of the linkage to glycerol of at least one fatty 
acid. ·However, alkaline hydrolysis fails to remove the fatty-
acid label completely from both anchors (data not shown). 
This behaviour may be in line with the observation that PLA2 
was also ineffective in the complete removal of the fatty-acid 
label, and leaves the possibility open that, in addition to one 
ester bond, an ether bond is involved (most likely at the sn-2-
position), guaranteeing membrane attachment of the protein 
after PLA2 treatment. 
Taken together, the results obtained from this series of 
experiments demonstrate that the lipid-anchor structure of 
the cAMP-binding protein from plasma membranes contains 
constituents which are likely to be linked in a similar fashion as 
found in trypanosomal VSG and a number of GPI-anchored 
ectoproteins from vertebrates. The mitochondrial membrane 
anchor appears to constitute a new, less complex type of 
lipid anchor. Although it contains PtdIns and Etn, it lacks 
carbohydrate residues. 
DISCUSSION 
A number of indications for the existence of additional 
cAMP-binding proteins in the cytoplasm [50, 51], plasma 
membranes [31] and mitochondria of yeast [19, 33] have spo-
radically appeared in the literature. These cAMP-binding 
species were, however, mainly regarded as artifacts caused by 
contaminating soluble R subunits of cytoplasmic PKA or by 
degradation products thereof [12]. This interpretation was 
encouraged by a number of extraordinary properties of the 
well-known cytoplasmic cAMP-binding proteins. In higher 
organisms, this protein was found to be amphipathic. The R2 
isoform, in particular, occurs as a soluble and a membrane-
associated form, depending on the cell type and the organism 
[52-57]. A similar amphipathic nature was recently also re-
ported for PKA from yeast, which was observed to occur 
associated with the inner surface of the plasma membrane 
[16]. Furthermore, smaller cAMP-binding entities, which sub-
sequently turned out to be degradation products of the R 
subunit of PKA, were still capable of binding cAMP [12, 
50, 51]. The omnipresence of proteolytic artifacts made it 
extremely difficult to prove the authenticity of cAMP-binding 
proteins with molecular masses below 52 kDa. The original 
publication on cAMP-binding proteins present in yeast 
plasma membranes [31] had described four photoaffinity-
labeled species with, in part, very low molecular masses. 
Lastly, later intense research in this laboratory and others for 
the structural gene of an R-subunit isoprotein in yeast had 
remained unsuccessful. Since heterologous hybridizations 
with DNA fragments and degenerate oligonucleotides 
synthesized according to the conserved consensus of cAMP-
binding domains failed, it had even prematurely been con-
cluded that yeast contains only a single cAMP-binding pro-
tein, namely the R subunit ofPKA [14,15]. This conclusion 
was particularly facilitated by the fact that genetic approaches 
had also failed to disclose the gene(s) of possible isoproteins. 
Strains mutated in the gene for the R subunit of PKA (e.g. 
sral) show an altered phenotype in which storage-carbo-
hydrate metabolism, entry into mitosis and, in diploids, mei-
osis are severely affected [13]. This phenotype could not be 
healed by overexpression of any other yeast gene. Using both 
a genetic and a biochemical approach, we show in the present 
paper that yeast harbours at least two genetically distinct 
proteins capable of binding cAMP. The strongest argument 
in support of this conclusion is dereived from a sral mutant 
in which the structural gene encoding the R subunit of PKA 
has been destroyed and which nevertheless displays two mem-
brane-bound protein species which can be labeled with a 
photoreactive cAMP derivative. One of these is even larger 
than the R subunit ofPKA and is located at the outer surface 
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Fig, 9, Chemical and enzymic analysis of the membrane anchors of the cAMP-binding proteins, Yeast cells were metaboJically labeled with 
[3H]ethanolamine (A), [3H]myo-inositol (B), [3H]myristic acid for isolation of plasma membranes (C, D and E; open bars) or [3H]stearic acid 
for the isolation ofrnitochondria (C, D and E; filled bars) and plasma membranes and mitochondria were prepared, Solubilized and affinity-
purified cAMP-binding proteins were then subjected to digestion by pronase E from S. aureus (A); cross-hatched bars, additional digestion 
with N-glycanase, nitrous acid dearnination (B), phospholipase D (from human serum) treatment (C), acetolysis (D) and base hydrolysis (E), 
respectively. After lipid extraction the organic phases were analysed by TLC. Radioactivity was determined using a linear TLC analyser. Each 
bar represents the mean of four independent experiments. Authentic fatty acids, Iipids and lipid derivatives were separated in parallel lanes 
on the same plates and their positions indicated on top of each diagram. 0, Origin; Fr, front; S, stearic acid; M, myristic acid; A, 
monomyristoylglycerol; B, 1,2-dimyristoylglycerol; C, 1,3-dimyristoylglycerol; D, 1,2-distearoyl-3-acetylglycerol; E, 1,2-dimyristoyl-3-
acetylglycerol; F, 1,3-dimyristoyl-2-acetylglycerol; G, trimyristoylglycerol; H, methyl myristate; PIP, phosphatidylinositol phosphate; PIP2 , 
phosphatidylinositol bisphosphate; PC, phosphatidylcholine; PI, phosphatidylinositol; PE, dimyristoylglycerophosphoethanolarnine; PG, 
dimyristoylglycerophosphoglycerol; PM, dimyristoylglycerol phosphate; PS, distearoylglycerol phosphate; NL, neutrallipids; PA, l-myristoyl-
2-acetylglycerol phosphate 
[23 a] of the plasma membrane, whereas the other occurs in 
mitochondria. The location in compartments different from 
PKA may also explain the failure to isolate sral-comp-
lementing genes. In addition to topology, we assayed a number 
of biochemical and immunological parameters in order to 
examine the structural relationship between these two cAMP-
binding proteins and the R subunit ofPKA. Support in favour 
of non-relatedness comes from experiments where all three 
cAMP-receptor proteins have been treated with proteases. 
Complete digestion of the affinity-purified, photolabeled, then 
denatured proteins yields cAMP-binding-peptide domains 
which differ strongly in size, dependent on whether they are 
derived from the cytoplasmic or from the two membrane-
bound proteins. This reveals an obvious difference in primary 
structure which can also be the reason why heterologous hy-
bridization has failed to unmask the genes for further cAMP-
binding proteins. The immunological data are not in conflict 
with this conclusion. 
Comparison of the two-membrane-bound cAMP-receptor 
proteins reveals both differences and similarities. The two are 
located in different compartments [19] and our unpublished 
results and the mature proteins differ in molecular masses. 
They resemble one another, however, in that both are embed-
ded in a membrane by a post-translationally attached lipid 
moiety. Interestingly, these two proteins represent the first 
examples of lipid-anchored cAMP-binding proteins. 
Although the nature and exact arrangement of compo-
nents appears to differ partly in the two anchors, they both 
contain PtdIns and Etn. In the cAMP receptor from plasma 
membranes, these two constituents are apparently linked by 
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a bridge containing non-acetylated GleN and Man (absent 
from the mitochondrial protein). Thus, the anchor of the 
cAMP receptor from plasma membranes closely resembles the 
GPI found in the VSG from trypanosomes and in a rapidly 
increasing number of eukaryotic ectoproteins. 
Mouse monoclonal antibodies against the R and Cl subunits of 
yeast PKA were donated by E. G. Krebs, Seattle. Anti-(VSG-CRD) 
serum, reactive in trypanosomes, was a gift from A. Mehlert and 
M. A. Ferguson, Dundee. Two different anti-YSG sera, together with 
the respective soluble YSG, an anti-(VSG-CRD) serum and GPI-
specific phospholipase C from T. brucei were kindly provided by P. 
Overath, Tubingen. PI-specific phospholipase C from Bacillus 
thuringiensis and phospholipase D from rabbit serum were gracious 
gifts from W. Gutensohn, University of Munich. We wish to thank 
K. Tatchell, North Carolina State University, Raleigh, for sending us 
the sral-disrupted strain, EG273-5A. We are grateful also to G. A. M. 
Cross, New York, for sending us a pre-edited version of his review 
article prior to pUblication. The work was, in part, supported by a 
grant from the Deutsche Forschungsgemeinschaft to W. Bandlow. 
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